How dangerous is the peptide grey market?

Very. Of 469 BPC-157 samples tested in 2026, 68% failed on quality, doses off by up to 80%. Why: a peptide is cheap to copy and the FDA's 2023 crackdown pushed users to "research use only" vendors. Crypto-paid peptide sales pass $100 million a year. 2 women in Las Vegas ended in hospital after unknown peptides at an anti-aging clinic. If it did not come from a pharmacy with your name on it, do not inject it.